Literature DB >> 9240803

Psychiatric symptoms in preadolescents with musculoskeletal pain and fibromyalgia.

M Mikkelsson1, A Sourander, J Piha, J J Salminen.   

Abstract

OBJECTIVES: To study the association of musculoskeletal pain with emotional and behavioral problems, especially depressive symptoms in Finnish preadolescents. STUDY
DESIGN: A structured pain questionnaire was completed by 1756 third- and fifth-grade schoolchildren for identifying children with widespread pain (WSP), children with neck pain (NP), and pain-free controls for the comparative study. There were 124 children with WSP (mean age, 10.7 years), 108 children with NP (mean age, 11.1 years), and 131 controls (mean age, 10.7 years) who completed the Children's Depression Inventory (CDI) and a sleep questionnaire. A blinded clinical examination was done to detect fibromyalgia. For parental evaluation, the Child Behavior Checklist and a sociodemographic questionnaire were used. For teacher evaluation the Teacher Report Form was used.
RESULTS: Children with WSP had significantly higher total emotional and behavioral scores than controls, according to child and parent evaluation. A significant difference in the mean total CDI scores was also found between the WSP and NP groups. Children with fibromyalgia had significantly higher CDI scores than the other children with WSP.
CONCLUSIONS: Musculoskeletal pain, especially fibromyalgia, and depressive symptoms had high comorbidity. Pain and depressive symptoms should be recognized to prevent a chronic pain problem.

Entities:  

Mesh:

Year:  1997        PMID: 9240803     DOI: 10.1542/peds.100.2.220

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

Review 1.  [Risk factors for back pain in children and adolescents].

Authors:  A Roth-Isigkeit; J Schwarzenberger; W Baumeier; T Meier; M Lindig; P Schmucker
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

Review 2.  Epidemiology of low back pain in children and adolescents.

Authors:  G T Jones; G J Macfarlane
Journal:  Arch Dis Child       Date:  2005-03       Impact factor: 3.791

3.  Psychiatric Disorders in Young Adults Diagnosed with Juvenile Fibromyalgia in Adolescence.

Authors:  Natoshia Raishevich Cunningham; Susan T Tran; Anne M Lynch-Jordan; Tracy V Ting; Soumitri Sil; Daniel Strotman; Jennie G Noll; Scott W Powers; Lesley M Arnold; Susmita Kashikar-Zuck
Journal:  J Rheumatol       Date:  2015-09-15       Impact factor: 4.666

4.  Chronic multisite pain in adolescent girls and boys with emotional and behavioral problems: the Young-HUNT study.

Authors:  Marit Skrove; Pål Romundstad; Marit S Indredavik
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-20       Impact factor: 4.785

Review 5.  Pain syndromes in children.

Authors:  D D Sherry
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

Review 6.  Juvenile primary fibromyalgia syndrome.

Authors:  K K Anthony; L E Schanberg
Journal:  Curr Rheumatol Rep       Date:  2001-04       Impact factor: 4.592

7.  Is insufficient quantity and quality of sleep a risk factor for neck, shoulder and low back pain? A longitudinal study among adolescents.

Authors:  Juha P Auvinen; Tuija H Tammelin; Simo P Taimela; Paavo J Zitting; Marjo-Riitta Järvelin; Anja M Taanila; Jaro I Karppinen
Journal:  Eur Spine J       Date:  2009-11-20       Impact factor: 3.134

8.  [Juvenile fibromyalgia syndrome].

Authors:  H Michels; K Gerhold; R Häfner; W Häuser; A Illhardt; K Mönkemöller; M Richter; L Schuchmann
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

9.  Genetic and environmental influences on non-specific neck pain in early adolescence: a classical twin study.

Authors:  M K Ståhl; A A El-Metwally; M K Mikkelsson; J J Salminen; L R Pulkkinen; R J Rose; J A Kaprio
Journal:  Eur J Pain       Date:  2012-11-09       Impact factor: 3.931

Review 10.  Juvenile fibromyalgia: current status of research and future developments.

Authors:  Susmita Kashikar-Zuck; Tracy V Ting
Journal:  Nat Rev Rheumatol       Date:  2013-11-26       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.